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Abstract
UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (GalNAc-transferases)
catalyze an initial step of mucin-type carbohydrate biosynthesis by transferring GalNAc to a
hydroxylamino acid on acceptor proteins. It is reported that the GalNAc-transferases catalyze
two distinguishable reactions; one is the initial reaction that transfers GalNAc to unglycosy-
lated acceptors, and the other is the follow-up reaction that glycosylates partially glycosylated
acceptors. Here, I report the structure-function relationship of the Gal/GalNAc-T motif, which
occurs in both the GalNAc-transferases and the β4-galactosyltransferases. I investigated the
role of the six conserved aromatic residues in this motif in GalNAc-T1, one of the most ubiq-
uitous isozymes, and evaluated the role of each aromatic residue, using site-directed mutage-
nesis, as follows. 1) Tyr302 and Phe325 might not be important for reaction. 2) Phe303 and
Tyr309 might be modestly involved in the interactions with both the sugar-donor and sugar-
acceptor substrates. 3) Trp328 and Trp316 are important sites for enzymatic activity, since the
mutations at either site resulted in complete inactivation of the enzyme. I then investigated
the role of Trp328 and Trp316 in more detail by generating additional mutants and analyzing
the resultant mutants kinetically. Their role was deduced as follows. 1) Trp328 is an essential
residue for the activity, since all the mutants generated were inactive and Trp328 is conserved
in all the isozymes cloned to date. 2) An aromatic residue is required for the activity at the
position of 316. 3) Trp316 is an important binding site with acceptors, primarily involved in
the initial glycosylation of acceptor polypeptides. This study first pinpointed the location of
the amino acid residue associated with the initial activity of the GalNAc-transferases.
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1. Introduction
Mucin-type O-glycosylation of proteins is one of the most important post-translational
modifications in the cells [1,2]. Its biosynthetic initial step is catalyzed by a large family of
UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (EC 2.4.1.41) (GalNAc-
transferases) by transferring GalNAc from UDP-GalNAc to Ser/Thr residues of proteins [1–3].
To date, 14 members of the mammalian GalNAc-transferase family have been identified [4–21].
They all have common structural features; the presence of an N-terminal cytoplasmic tail, fol-
lowed by a transmembrane region, a stem region, a putative catalytic domain, and a C-terminal
lectin domain that consists of the three tandem (QXW)3 repeats (Fig. 1A). The catalytic domain
contains two subdomains; the GT1 motif and the Gal/GalNAc-T motif [22].
It is reported that the reaction catalyzed by the GalNAc-transferases consists of two mech-
anisms that proceed in biochemically distinct manners; one is the initial glycosylation, and the
other the follow-up glycosylation [23–26]. The former is the reaction that transfers GalNAc to
unglycosylated acceptors. The latter reaction is involved in the glycosylation of partially gly-
cosylated acceptors and is dependent on the recognition of GalNAc residues on the acceptors
by the lectin domain of the enzymes. As a consequence, the follow-up activity is inhibited by
free GalNAc, while the initial activity is not. Some isozymes, such as GalNAc-T4 and -T7, are
reported to predominantly catalyze the follow-up reaction [8,12]. Recently, I demonstrated that
GalNAc-T1, which is one of the most ubiquitous isozymes and had been regarded as having
the initial glycosylation activity, catalyzes both the initial and the follow-up reactions [26,27].
I also showed that the lectin domain of GalNAc-T1 is functional, and identified aspartic acid in
the α repeat of the (QXW)3 repeats to be predominantly involved in the follow-up reaction. By
contrast, no structural information on the initial activity is available so far.
In this report, I investigated the structure-function relationship of the Gal/GalNAc-T mo-
tif of GalNAc-T1. Although it is reported that the Gal/GalNAc-T motif, a sequence similarly
found in β4-galactosyltransferases, contains the essential carboxylates for the GalNAc-T1 ac-
tivity [22], the functional role of this motif still remains to be elucidated. I investigated the role
of the conserved aromatic amino acid residues in the Gal/GalNAc-T motif using site-directed
mutagenesis and kinetic analysis of the mutants. I found that some of the aromatic residues
in this domain are involved in binding with both the sugar donor and the acceptor substrates.
Among them, invariant Trp328 was found to be essential for the enzyme activity of GalNAc-
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Fig. 1 Schematic representation of GalNAc-T1 and P-∆N42, and sequence comparison of the
Gal/GalNAc-T motif among isozymes
A) Schematic representation of GalNAc-T1 and P-∆N42. B) Amino acid alignment of the Gal/GalNAc-T
motif. Identical amino acid residues are boxed. Closed circles indicate essential acidic residues for the
activity of GalNAc-T1 [22].
T1. I also report the structural element required for the initial activity for the first time. Trp316
in the Gal/GalNAc-T motif was an important residue related to the initial activity.
2. Materials and Methods
2.1 Site-directed mutagenesis of soluble rat recombinant GalNAc-T1
Rat GalNAc-T1 cDNA was obtained as outlined by Hagen et al.[28]. The plasmid,
pInsProA∆N42, containing cDNA for soluble, tagged, rat GalNAc-T1 was prepared by deleting
the coding sequence for the cytoplasmic tail and the transmembrane domain from
full-length GalNAc-T1 cDNA, and by fusing cDNA for an insulin signal sequence and a
Protein A-IgG binding domain to the resulting 5’-end of the truncated GalNAc-T1 cDNA
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as described previously [29]. Site-directed mutagenesis on pInsProA∆N42 was performed
using primers listed below [29]. Nucleotides expressed in boldfaces are altered nucleotides to
introduce mutations to GalNAc-T1. Y302L, ATTTCCTGAAAGAGATCTCT; F303L,
ATTTCCTGAAGGTAATCTCT; Y309L, TTCCAGCATCAGCTGTTCCA; W316Y,
TTCTCCTCCATAAATATCCA; W316F, TTCTCCTCCGAAAATATCCA; W316L,
TTCTCCTCCGAGAATATCCA; W316A, TTCTCCTCCCGCAATATCCA; W316H,
TTCTCCTCCGTGAATATCCA; F325L, CTGCCAAATCCTAAGGGAAA; W328L,
CACACTGCAGAATCCTAAAG; W328A, CACACTGCGCAATCCTAAAG; W328Y,
CTGATAAATCCTAAAGGAAA; W328F, CTGGAAAATCCTAAAGGAAA. The nucleotide
sequence of the mutant clones was verified by DNA sequencing using ALFexpress II (Amer-
sham Pharmacia Biotech).
2.2 Expression of P-∆N42 and mutant P-∆N42 in COS7 cells
The fusion protein (P-∆N42), containing a Protein A-IgG binding domain at the N-terminus,
and mutant P-∆N42 were expressed in COS7 cells and purified from the conditioned medium
as described previously [29]. SDS-PAGE and Western blotting of the recombinant molecules
were also carried out as described [29]. The protein bands on the immunoblots were scanned
and quantitated with a Luminoimage Analyzer LAS-1000 PLUS (Fujifilm). The activities of
P-∆N42 and mutant P-∆N42 were determined as described below and the activity levels were
corrected for the enzyme protein concentration in the medium.
2.3 GalNAc-transferase assay
GalNAc-transferase assays using apomucin and peptide acceptors as acceptors were carried
out as described in [29] and [26], respectively. Kinetic analysis of P-∆N42 and its mutants were
carried out as described previously [29].
3. Results
3.1 Mutagenesis of the conserved aromatic residues in the Gal/GalNAc-T motif
Amino acid sequence alignment of the Gal/GalNAc-T motif among the GalNAc-
transferases (Fig. 1B) shows that this motif contains six highly conserved aromatic amino acid
residues among the isozymes (Tyr302, Phe303, Tyr309, Trp316, Phe325, and Trp328). Among
them, Trp328 is the only residue that is strictly conserved within all the GalNAc-transferases
cloned to date. The other aromatic amino acids, although highly conserved, are replaced in
some of the isozymes. However, the substitution of these residues is conservative in most
cases; i.e., they are replaced by another aromatic residue, such as phenylalanine, tryptophan,
and tyrosine, suggesting the functional importance of aromatic residues at these sites.
In order to evaluate the role of the conserved aromatic residues in the Gal/GalNAc-T mo-
tif, I carried out site-directed mutational analysis on these residues. I used the recombinant
rat GalNAc-T1 for this experiment. The recombinant enzyme was constructed by deleting
the cytoplasmic tail and the transmembrane region from the rat isozyme and by fusing an in-
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sulin signal sequence and a protein A-IgG binding domain to the resulting N-terminus of the
truncated GalNAc-T1 (Fig. 1A). The recombinant GalNAc-T1 thus prepared was expressed in
COS7 cells and the secreted fusion protein (P-∆N42), which lacks N-terminal 42 amino acid
residues of the enzyme, was purified from the culture medium on IgG-Sepharose as described
under Materials and Methods. As reported previously [29], P-∆N42 is fully active, having al-
most identical Km values for the sugar donor and the acceptor substrates as compared with the
full-length GalNAc-T1.
I first prepared the single point mutants of P-∆N42, in which the respective aromatic residue
was replaced by a leucine residue (Fig. 2). Leucine does not contain an aromatic ring, but is
as hydrophobic as the aromatic amino acids. It is, therefore, expected that the substitution of
leucine for an aromatic residue may minimize the local conformational change in the enzyme
molecules due to the altered hydrophobicity and make it possible to evaluate the functional
role of the replaced aromatic residues. P-∆N42 and its single-point mutants were expressed in
COS7 cells and the secreted fusion proteins were recovered from culture medium. The amount
of secreted fusion protein was evaluated by Western blotting, as described under Materials and
Methods. For the assay for the activity, apomucin was used as an acceptor. Apomucin is an
efficient substrate of GalNAc-T1 and is characterized by the presence of multiple acceptor sites
on the polypeptide [30–35]. The enzymatic activity was corrected for recombinant protein
expression and expressed as the relative activity to that of P-∆N42.
Fig. 2 shows that the protein expression level of all the six leucine mutants was roughly
Fig. 2 Expression and enzymatic activity of GalNAc-T1 mutant enzymes
P-∆N42 and mutant enzymes were expressed in COS7 cells and the secreted recombinant proteins in
the medium were recovered from the medium. The mutant enzymes were purified on IgG-Sepharose as
described under Materials and Methods. The amount of the secreted protein was determined by Western
blotting followed by the densitometric scanning of the blot (lower panel). The enzymatic activity secreted
in the medium was determined using apomucin as acceptor and corrected for the amount of the mutant in
the medium and expressed as the relative activity to that of the wild type, P-∆N42. The solid bars show
the percent enzyme activity relative to that of P-∆N42 (hatched bar).
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comparable to that of the P-∆N42. On the other hand, the relative activity of these mutants
was significantly reduced. Especially, the activity of the two mutants (W316L and W328L)
was decreased almost to the background level, suggesting the functional importance of these
residues. By contrast, the other four mutants (Y302L, F303L, Y309L, and F325L) exhibited
more moderately reduced activity at the levels of 40–80％ of the parent enzyme.
3.2 Kinetic analysis of the mutant enzymes
In order to evaluate the catalytic roles of the aromatic residues, I investigated kinetic prop-
erties of four leucine mutant enzymes that retained activity to allow the kinetic analysis (Table
1). First, the Km values were determined for the donor substrate, UDP-GalNAc. Of the mutants
examined, the affinity of F303L and Y309L was most severely affected with the approximately
3-fold increase in Km values. On the other hand, no significant alteration was observed for
the mutants, Y302L and F325L, which retained the highest activities with apomucin among the
mutants (Fig. 2). Affinity of the mutants for the sugar acceptor, apomucin, was also investigated
(Table 1). The affinity of F303L for apomucin was decreased as well, with approximately 3-
fold increase in the Km value. No significant or only modest change in Km values was observed
for the other mutants. The kinetic study of the mutants indicates that some of the aromatic
amino acids in the Gal/GalNAc-T motif are involved in the binding with both UDP-GalNAc
and apomucin.
3.3 Mutagenesis of Trp316 and Trp328 in the Gal/GalNAc-T motif
Among the six leucine mutants, the activity of W316L and W328L were most severely
affected (Fig. 2). To examine the importance of the aromatic residues at these two positions,
I prepared several additional mutants (Figs. 3A and B). As to the position 316, four mutants
(W316Y, W316F, W316A, and W316H) were generated. Of these, W316Y and W316F, in
which tryptophan was replaced by another aromatic amino acid, tyrosine and phenylalanine,
respectively, exhibited significantly higher activity than W316L, with approximately 40％ and
20％ of the activity of the wild type, respectively. The preference of tryptophan and tyrosine to
phenylalanine may suggest the requirement of an indole group or an aromatic ring with a polar
Table 1 Kinetic analysis of the leucine mutants
UDP-GalNAc apomucin
Km (mM) -fold Km (mg/ml) -fold
P-∆N42 5.1±0.8 1.0 4.7±0.1 1.0
Y302L 5.2±0.1 1.0 5.0±0.2 1.0
F303L 14.2±1.1 2.8 13.6±1.9 2.8
Y309L 16.0±0.3 3.2 7.1±0.4 1.5
F325L 6.2±0.6 1.2 6.7±1.7 1.4
Km for UDP-GalNAc and apomucin was determined as described under Materials
and Methods. Values are the average of three distinct reactions.
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Fig. 3 Expression and enzymatic activity of mutant enzymes at Trp316 and Trp328
Expression and enzyme assay of P-∆N42 and the mutant proteins were carried out as described in the
legends to Fig. 2. The solid bars show the percent enzyme activity relative to that of P-∆N42 (hatched
bar). A) Mutants at Trp316 and B) mutants at Trp328.
functional group at this site. W316H contains a polar imidazole group, instead of an aromatic
group at this site. This mutant, however, was completely inactive. W316A had no activity, as
would be expected by the loss of the aromatic ring and by the low hydrophobicity of alanine.
Consequently, an aromatic amino acid is considered essential at the position 316 for the activity
and moreover, the aromatic residue with a polar functional group would be more favorable.
I, then, investigated the role of Trp328. Similarly, I generated three additional mutants,
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W328Y, W328F, and W328A. Contrary to the position 316, these three mutants were com-
pletely inactive (Fig. 3B). This indicates that the tryptophan residue is essential at the position
328 for the GalNAc-T1 activity. It is noteworthy that Trp328 is strictly conserved within all
known isozymes, suggesting that it serves the important function common to the family.
3.4 Kinetic analysis of the Trp316 mutant enzymes
To investigate the functional role of Trp316 in catalysis, I carried out the kinetic analysis of
W316Y andW316F (Table 2). The two mutants exhibited modestly decreased affinity for UDP-
GalNAc. On the other hand, their affinity for apomucin was more severely affected. Moreover,
the reduced affinity for apomucin of these mutants was correlated well with the reduced activity
(Fig. 3A and Table 2). W316F, which had lower activity than W316Y, exhibited lower affinity
for apomucin with 9.1-fold increase in Km value. This indicates that Trp316 is the major site
interacting with the acceptors. A polar group would be necessary for the efficient binding with
acceptors, as demonstrated by the low affinity of W316F.
3.5 Trp316 is involved in the initial glycosylation of an acceptor polypeptide
Since apomucin contains multiple glycosylation sites, the altered Km values for apomucin
include the overall decrease in the affinity related to both the initial and the follow-up activity
(Fig. 3A and Table 2). In the previous report, I demonstrated that the inclusion of a high con-
centration of free GalNAc in the reaction interferes with binding of the enzymes to partially
glycosylated acceptors, and selectively inhibits the successive follow-up glycosylation [25,26].
Hence, the enzymatic activity remaining in the presence of a high concentration of GalNAc rep-
resents the initial O-glycosylation activity of the mutants. I investigated the effects of GalNAc
on the glycosylation of apomucin by W316Y and W316F. If the mutation at 316 primarily af-
fects the initial glycosylation of apomucin, the inhibition by GalNAc should be more prominent
in the mutants. This was, indeed, the case with the W316F and W316Y (Fig. 4). In addition,
W316F, which had lower activity with apomucin than W316Y, was more severely inhibited by
free GalNAc. These data indicate that the reduced glycosylation of apomucin by W316F and
Table 2 Kinetic analysis of the Trp316 mutants
UDP-GalNAc apomucin
Km (mM) -fold Km (mg/ml) -fold
P-∆N42 5.1±0.8 1.0 4.7±0.1 1.0
W316Y 9.0±0.1 1.8 17.4±3.6 3.6
W316F 9.1±0.7 1.8 43.9±3.8 9.1
Km for UDP-GalNAc and apomucin was determined as described under Materials
and Methods. Values are the average of three distinct reactions.
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Fig. 4 Inhibition of P-∆N42 and the Trp316 mutants with free GalNAc
Recombinant enzymes, expressed in COS7 cells and purified from the conditioned medium on IgG-
Sepharose, were assayed for the activity using apomucin as acceptor in the presence of increasing con-
centrations of GalNAc. ■, P-∆N42;●, W316Y;▲, W316F.
W316Y can be primarily ascribed to the decreased initial glycosylation.
3.6 Involvement of Trp316 in the binding of acceptor peptides with a single acceptor site
I determined the activity of W316Y andW316F to glycosylate peptides with a single accep-
tor site, in order to evaluate the effect of the mutation on the initial glycosylation of acceptors.
In this experiment, I used two synthetic peptides, PPDAATAAPL and GVVPTVVPG, which
are efficient acceptors of GalNAc-T1 [3,26]. As I expected, the two mutants had drastically
decreased activity with these peptides (Fig. 5), while they retained significant activity with apo-
mucin (Fig. 3A). This also supports the idea that Trp316 is the major site involved in the initial
glycosylation.
The kinetic analysis of W316Y and W316F was also carried out using these two peptides.
Table 3 shows that the decrease in the activity of W316Y and W316F was primarily ascribed
to the reduced affinity of the mutants for the acceptors. Considering the moderately reduced
affinity for UDP-GalNAc of the mutants (Table 2), the increase in Km for both peptides, for
the most part, accounts for the low activity of the mutants. These results indicate that Trp316
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Fig. 5 Enzyme activity of P-∆N42 and the Trp316 mutants with peptides with a single acceptor site
Hatched, solid, and white bars indicate the enzyme activity of P-∆N42, W316Y, and W316F, respectively.
in GalNAc-T1 serves as an important binding site for the initial glycosylation of the acceptor
polypeptides.
4. Discussion
In this study, I demonstrated that the Gal/GalNAc-T motif participates in the binding with
both the sugar donor and acceptor substrates based on the combination of site-directed muta-
genesis and kinetic analysis of the mutant enzymes. I also identified some of the conserved
aromatic residues to be involved in the enzyme function. The effects of the mutations were de-
pendent on the positions of the mutated aromatic residues (Fig. 2 and Table 1). The mutations at
Tyr302 and Phe325 gave only a minor reduction (20–30％) in the activity. Kinetic analysis also
showed that these sites are basically unrelated to binding with the substrates. On the other hand,
the mutations at Phe303 and Tyr309 caused moderately reduced activity with reduced affinities
for both UDP-GalNAc and apomucin. This suggests that these residues may weakly interact
with both the sugar donor and the acceptor substrates. These residues are highly conserved, al-
though conservatively substituted by other hydrophobic amino acids in some isozymes (Fig. 1).
They may not be crucial for the basic catalytic function of GalNAc-transferases, but rather im-
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portant in defining the catalytic properties of some of isozymes. Contrary to these residues,
all the mutations at Trp328 (W328L, W328A, W328Y, and W328F) resulted in complete in-
activation of the enzyme (Figs. 2 and 3). This, together with the fact that Trp328 is strictly
conserved within all known isozymes, suggests that this residue may serve the basic enzyme
function common to the family (Fig. 1). As to Trp316, the mutational effects depend on the
type of substituted amino acids. When leucine, alanine, or histidine was introduced, enzymatic
activity was lost. On the other hand, substitution with another aromatic residue, such as tyro-
sine and phenylalanine, gave a reduced, but significant activity (W316Y and W316F) (Figs. 2
and 3). All these results, together with the increased sensitivity of the mutant of the inhibition
by free GalNAc, indicate that Trp316 is a biding site with acceptor peptide to perform the initial
glycosylation.
It seems likely that the GalNAc-transferases have a repertoire of amino acid residues (sub-
sites) that can interact with the acceptor substrates [3,36,37]. Supposedly, there would be nu-
merous combinations of the interactions between substrates and the substrate-binding sites of
the GalNAc-transferases, which might determine the binding affinity for the acceptors. As
a consequence, the enzyme would have broad rather than defined substrate specificity as re-
ported, and the variation in the subsites could provide each isozyme with distinct kinetic prop-
erties [1,3,36,38,39]. This report demonstrated that Trp316 is one of the important subsites in
GalNAc-T1. This is supported by the fact that the mutation at 316 in GalNAc-T1 selectively
impaired their initial activity (Figs. 4 and 5, Table 3). In accordance with this, our preliminary
experiments using a panel of undecapeptides indicate that the activity of the mutants was, on the
whole, decreased to the level as low as a few percentages of that of the parent enzyme (personal
communications). It should be noted that Trp316 is conserved among the GalNAc-transferases
except GalNAc-T8 and GalNAc-T9 (Fig. 1). These two isozymes contain a tyrosine residue in
place of Typ316. Accordingly, they are expected to have a lower or restricted initial activity
than the other isozymes. Together with their restricted expression in the tissue [13,14], they
may catalyze tissue-specific glycosylation.
Clarified three-dimensional structure of the β4-galactosyltransferases demonstrates that
Trp314 in β4-galactosyltransferases, which corresponds to Trp316 in GalNAc-T1, interacts
with UDP-Gal [40–45]. Interestingly, Trp314 is involved in the conformational change of the
Gal/GalNAc-T motif, which occurs following the binding of UDP-Gal to the β4-
Table 3 Affinity of the Trp316 mutants for peptides
PPDAATAAPL GVVPTVVPG
Km (mM) -fold Km (mM) -fold
P-∆N42 0.35±0.05 1.0 1.74±0.3 1.0
W316Y 13.5±0.7 38.5 16.0±0.3 9.2
W316F 15.6±0.6 44.6 17.6±0.5 10.1
Km for peptides with a single acceptor site was determined as described under Mate-
rials and Methods. Values are the average of three distinct reactions.
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galactosyltransferases. This conformational change leads to alteration of the β4Gal-transferases
from the inactive to the active state, making the binding of the sugar acceptors as well as α-
lactoalbumin to the enzyme possible [40–45]. It may also be possible that Trp316 in GalNAc-
T1 plays a similar role in catalysis. Our kinetic data suggest that Trp316 can bind with both
UDP-GalNAc and the acceptor substrates (Tables 2 and 3). Moreover, GalNAc-T1 appar-
ently catalyzes the ordered reaction; the binding of UDP-GalNAc precedes the binding with
the acceptor substrates [3,26]. Thus, the binding of UDP-GalNAc to the binding sites in the
Gal/GalNAc-T motif may cause the conformational change in GalNAc-T1 and make the fol-
lowing interactions with the acceptors possible.
Here, I reported the role of the aromatic residues in the Gal/GalNAc-T motif in the bind-
ing with both UDP-GalNAc and the acceptor peptides for the first time. Through our present
and previous studies on the structure-function relationship of GalNAc-T1, I have demonstrated
that the characteristic domain structures of the GalNAc-transferases contribute to the common
function of this family. Still, basic characteristics of the GalNAc-transferases remain to be
elucidated, such as substrate specificity, and the detail mechanism of the initial and follow-up
activities. More in-depth analysis of each motif, using biochemical and molecular biologi-
cal approaches, together with crystallographic study of each enzyme, would be necessary for
understanding catalytic mechanism of the GalNAc-transferases.
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Footnotes
Abbrevations: EDTA, ethylenediaminetetraacetic acid; GalNAc, N-acetylgalactosamine;
GalNAc-transferase, UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase; GT1, gly-
cosyltransferase 1; PCR, polymerase chain reaction; SDS-PAGE, SDS-polyacrylamide gel
electrophoresis.
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UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase 1
(GalNAc-T1)の構造活性相関
――Gal/GalNAc-Tモチーフ中の保存された芳香族アミノ酸残基の機能解析――
天　　野　　麻　　理
要　旨
UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) は，糖タンパク質のムチン型糖鎖
生合成開始反応を触媒する酵素である．この酵素は，糖鎖を持たないペプチド上に GalNAc を転移する
initial 反応と，部分的に糖付加されたアクセプター上に GalNAc を転移する follow-up 反応という生化学
的に機構の異なる 2 つの反応を触媒することが知られている．筆者は，GalNAc-Tの中でも最も幅広い組
織分布を示す GalNAc-T1 をモデル酵素として，Gal/GalNAc-T モチーフの機能を調べた．このモチーフは
β4-galactosyltransferaseにも見いだされる配列であり，糖転移酵素に重要な機能を付与する配列であると考
えられている．筆者は，Gal/GalNAc-Tモチーフ内で高度に保存されている 6つの芳香族アミノ酸残基を部
位特異的に改変した変異体を作製し，それらの性質を解析することで次に示す結果を得た．1) Tyr302 と
Phe325は酵素活性に関与しない．2) Phe303と Tyr309は糖ドナーとアクセプターの両方の結合に関与する．
3) Trp328と Trp316は酵素活性に不可欠なアミノ酸残基である．Trp328と Trp316については，さらに多く
の種類の変異体を作製してより詳細な解析を行い，以下の知見を得た．1)すべてのアイソザイム間で保存さ
れている Trp328は GalNAc-T1の酵素活性に不可欠である．このトリプトファン残基を他のアミノ酸に改変
すると酵素は完全に失活した．2) 316番目の位置には芳香族アミノ酸残基が必要である．3) Trp316は基質
タンパク質との結合，特に initial反応に重要な役割を果たす．本研究を通じて，筆者は GalNAc-Tの initial
反応に関係するアミノ酸残基を同定することに初めて成功した．
キーワード：ムチン型 O-グリコシレーション，GalNAc転移酵素，Gal/GalNAc-Tモチーフ，構造活性相関，
部位特異的変異
